This paper is only available as a PDF. To read, Please Download here.
We compared the mechanisms by which caldesmon inhibits actin and actin-tropomyosin activation of myosin subfragment 1 (S1) MgATPase activity. Caldesmon always inhibited actin activation by displacing S1.ADP.Pi from actin and inhibition required at least 0.7 caldesmon molecules bond per actin for 90% inhibition. Caldesmon inhibited actin-tropomyosin without any displacement of S1.ADP.Pi; thus it inhibits a rate-limiting step. Inhibition is highly cooperative, requiring no more than one caldesmon bound per 10 actins for 90% inhibition of activation by actin and smooth muscle tropomyosin. The degree of cooperativity is defined by the tropomyosin since inhibition by skeletal tropomyosin requires up to one caldesmon bound per 4 actins for 90% inhibition under identical conditions. Both noncooperative inhibition of actin and cooperative, tropomyosin-dependent, inhibition are manifested by a fragment of caldesmon containing only the C-terminal 99 amino acids (658C), although this fragment does not itself bind to tropomyosin. The functional properties of 658C are very similar to striated muscle troponin I, consequently we propose a similar mechanism for tropomyosin-dependent regulation by caldesmon. Caldesmon binding switches actin-tropomyosin to the “off” or “weak” state and Ca2+/calmodulin binding to caldesmon blocks this switch and thus reactivates the actin filament.
REFERENCES
- Biochem. J.. 1990; 272: 305-310
- FEBS Lett.. 1991; 292: 179-182
- Biochem. J.. 1985; 231: 517-522
- J. Muscle Res. Cell Motil.. 1984; 5: 559-575
- Biochem. Biophys. Res. Commun.. 1988; 155: 197-202
- J. Biol. Chem.. 1987; 262: 116-122
- Biochem. J.. 1989; 257: 839-843
- Biochem. Biophys. Res. Com mun.. 1993; 190: 668-673
- Biochem. J.. 1991; 279: 1-16
- J. Biol. Chem.. 1992; 267: 16796-16800
- Biochim. Biophys. Acta.. 1985; 842: 70-75
- J. Biol. Chem.. 1990; 265: 15231-15238
- Biochem. Biophys. Res. Commun.. 1986; 136: 962-968
- Ann. N. Y. Acad. Sci.. 1990; 599: 85-99
- J. Biol. Chem.. 1987; 262: 5711-5716
- J. Biol. Chem.. 1990; 265: 2929-2934
- Biochemistry.. 1989; 28: 9111-9116
- J. Biol. Chem.. 1990; 265: 19672-19678
- J. Biol. Chem.. 1989; 264: 9602-9610
- Biochem. Soc. Trans.. 1979; 7: 593-617
- J. Biol. Chem.. 1984; 259: 2070-2072
- Biochemistry.. 1984; 23: 4150-4155
- J. Muscle Res. Cell Motil.. 1985; 6: 669-708
- Biophys. J.. 1981; 35: 99-112
- FEBS Lett.. 1986; 202: 182-186
- J. Biochem. (Tokyo).. 1987; 102: 1065-1073
- Biochemistry.. 1991; 30: 712-717
- J. Mol. Biol.. 1982; 157: 275-285
- J. Biol. Chem.. 1982; 257: 10587-10592
- J. Biol. Chem.. 1982; 257: 2432-2437
- J. Biol. Chem.. 1992; 267: 20497-20506
- Biochem. J.. 1991; 279: 711-718
- Biophys. J.. 1992; 63: 1063-1070
- J. Biol. Chem.. 1990; 265: 2231-2237
Article info
Publication history
Published online: June 15, 1993
Identification
Copyright
© 1993 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse
Elsevier's open access license policy

Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy